Antibiotic Treatment for Bacterial Keratitis
For bacterial keratitis, initiate treatment with topical fluoroquinolone monotherapy (ciprofloxacin 0.3%, ofloxacin 0.3%, or levofloxacin 1.5%) for mild-to-moderate cases, or fortified antibiotics (cefazolin + tobramycin or vancomycin + ceftazidime) for severe cases with central involvement, deep stromal infiltration, infiltrates >2mm, or hypopyon. 1
Treatment Algorithm Based on Severity
Mild-to-Moderate Keratitis (Small, Non-Central Ulcers)
Fluoroquinolone monotherapy is the first-line treatment:
- FDA-approved options: Ciprofloxacin 0.3%, ofloxacin 0.3%, or levofloxacin 1.5% 1
- Dosing: Apply every 1-2 hours while awake initially, then taper based on response
- Efficacy: Single fluoroquinolone therapy is as effective as fortified combination therapy for most community-acquired cases 1
Fourth-generation fluoroquinolones (moxifloxacin, gatifloxacin) offer superior gram-positive coverage and may heal faster:
- Recent network meta-analysis shows moxifloxacin heals 6.81 days faster than ciprofloxacin 2
- Better coverage against methicillin-resistant Staphylococcus than earlier fluoroquinolones 1
- Not FDA-approved for bacterial keratitis but perform as well or better than standard therapy in clinical trials 1
Severe Keratitis (Central Location, Deep Stromal Involvement, Infiltrate >2mm, or Hypopyon)
Fortified antibiotic combination therapy is preferred:
Best options based on 2025 network meta-analysis 2:
- Vancomycin + ceftazidime (fastest healing, SUCRA 83.8; fewest adverse effects, SUCRA 93.1)
- Cefazolin + tobramycin (SUCRA 71.3 for healing)
- Cefazolin + gentamicin (low adverse effects, SUCRA 82.5)
Dosing for severe cases 1:
- Loading dose: Every 5-15 minutes for first hour
- Maintenance: Every hour around the clock initially
- Continue until clinical improvement confirmed, then taper
Critical Resistance Considerations
Fluoroquinolone resistance is increasing 1:
- 42% of Staphylococcal isolates show methicillin resistance with concurrent fluoroquinolone resistance 1
- Risk factors: Recent fluoroquinolone use, hospitalization, advanced age, recent ocular surgery 1
- Streptococci and anaerobes have variable fluoroquinolone susceptibility 1
- Pseudomonas resistance to moxifloxacin increased from 19% to 52% in some regions 1
When resistance is suspected, switch to fortified antibiotics immediately rather than continuing ineffective fluoroquinolone therapy.
Adjunctive Measures
Cycloplegics: Use to reduce pain and prevent synechiae formation 1
Systemic antibiotics: Reserve for:
- Scleral extension
- Intraocular extension
- Impending/frank perforation
- Gonococcal keratitis (mandatory) 1
Corticosteroids: May add after 2-3 days of antibiotic therapy IF:
- Organism identified (NOT Nocardia or fungus)
- Epithelial defect healing
- Ulcer consolidating
- Central corneal involvement threatening vision 1
Common Pitfalls to Avoid
- Don't use ointments as primary therapy - poor corneal penetration; reserve for bedtime in mild cases 1
- Don't patch contact lens-related abrasions - increases bacterial keratitis risk 1
- Don't add corticosteroids to Nocardia infections - results in poor visual outcomes 1
- Don't delay fortified antibiotics in severe cases - higher MIC correlates with worse outcomes 1
- Don't assume fourth-generation fluoroquinolones work for Pseudomonas - resistance rates are high in some regions 1
Follow-Up Intensity
- Severe cases: Daily evaluation until stable improvement confirmed 1
- Mild-to-moderate cases: Every 2-3 days initially, adjust based on response